Chemicals - Specialty
Compare Stocks
4 / 10Stock Comparison
AVNT vs LIN vs EMN vs HUN
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Chemicals
AVNT vs LIN vs EMN vs HUN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty | Chemicals |
| Market Cap | $3.35B | $228.85B | $8.43B | $2.56B |
| Revenue (TTM) | $3.28B | $34.66B | $8.64B | $5.69B |
| Net Income (TTM) | $158M | $7.13B | $399M | $-324M |
| Gross Margin | 31.7% | 46.0% | 19.8% | 12.9% |
| Operating Margin | 9.3% | 28.8% | 9.4% | -1.0% |
| Forward P/E | 12.0x | 27.7x | 12.5x | — |
| Total Debt | $1.92B | $26.99B | $5.08B | $2.73B |
| Cash & Equiv. | $511M | $5.06B | $566M | $429M |
AVNT vs LIN vs EMN vs HUN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Avient Corporation (AVNT) | 100 | 147.3 | +47.3% |
| Linde plc (LIN) | 100 | 244.1 | +144.1% |
| Eastman Chemical Co… (EMN) | 100 | 108.2 | +8.2% |
| Huntsman Corporation (HUN) | 100 | 81.2 | -18.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AVNT vs LIN vs EMN vs HUN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AVNT is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 14 yrs, beta 1.19, yield 2.9%
- Lower volatility, beta 1.19, Low D/E 80.6%, current ratio 1.66x
- Beta 1.19, yield 2.9%, current ratio 1.66x
- Better valuation composite
LIN carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 3.0%, EPS growth 7.1%, 3Y rev CAGR 0.6%
- 375.2% 10Y total return vs HUN's 57.6%
- PEG 1.09 vs EMN's 3.89
- 3.0% revenue growth vs EMN's -6.7%
EMN lags the leaders in this set but could rank higher in a more targeted comparison.
HUN is the #2 pick in this set and the best alternative if dividends and momentum is your priority.
- 5.7% yield, vs AVNT's 2.9%
- +37.5% vs EMN's +2.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.0% revenue growth vs EMN's -6.7% | |
| Value | Better valuation composite | |
| Quality / Margins | 20.6% margin vs HUN's -5.7% | |
| Stability / Safety | Beta 0.24 vs HUN's 1.73, lower leverage | |
| Dividends | 5.7% yield, vs AVNT's 2.9% | |
| Momentum (1Y) | +37.5% vs EMN's +2.3% | |
| Efficiency (ROA) | 8.3% ROA vs HUN's -4.6%, ROIC 11.3% vs -0.6% |
AVNT vs LIN vs EMN vs HUN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AVNT vs LIN vs EMN vs HUN — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LIN leads in 4 of 6 categories
HUN leads 1 • AVNT leads 0 • EMN leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
LIN leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 10.6x AVNT's $3.3B. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to HUN's -5.7%. On growth, LIN holds the edge at +8.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $3.3B | $34.7B | $8.6B | $5.7B |
| EBITDAEarnings before interest/tax | $445M | $12.1B | $1.2B | $160M |
| Net IncomeAfter-tax profit | $158M | $7.1B | $399M | -$324M |
| Free Cash FlowCash after capex | $205M | $5.1B | $498M | $135M |
| Gross MarginGross profit ÷ Revenue | +31.7% | +46.0% | +19.8% | +12.9% |
| Operating MarginEBIT ÷ Revenue | +9.3% | +28.8% | +9.4% | -1.0% |
| Net MarginNet income ÷ Revenue | +4.8% | +20.6% | +4.6% | -5.7% |
| FCF MarginFCF ÷ Revenue | +6.3% | +14.7% | +5.8% | +2.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.5% | +8.2% | -4.9% | +0.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +3.8% | +13.4% | -40.8% | -3.3% |
Valuation Metrics
HUN leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 18.0x trailing earnings, EMN trades at a 56% valuation discount to AVNT's 41.0x P/E. Adjusting for growth (PEG ratio), LIN offers better value at 1.33x vs EMN's 5.59x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $3.3B | $228.8B | $8.4B | $2.6B |
| Enterprise ValueMkt cap + debt − cash | $4.8B | $250.8B | $12.9B | $4.9B |
| Trailing P/EPrice ÷ TTM EPS | 41.01x | 33.85x | 17.97x | -9.27x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.95x | 27.67x | 12.50x | — |
| PEG RatioP/E ÷ EPS growth rate | — | 1.33x | 5.59x | — |
| EV / EBITDAEnterprise value multiple | 12.22x | 19.75x | 8.96x | 19.64x |
| Price / SalesMarket cap ÷ Revenue | 1.03x | 6.73x | 0.96x | 0.45x |
| Price / BookPrice ÷ Book value/share | 1.40x | 5.82x | 1.41x | 0.86x |
| Price / FCFMarket cap ÷ FCF | 17.16x | 44.97x | 19.87x | 22.11x |
Profitability & Efficiency
LIN leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-8 for HUN. LIN carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to HUN's 0.92x. On the Piotroski fundamental quality scale (0–9), LIN scores 6/9 vs HUN's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.6% | +17.8% | +6.7% | -8.1% |
| ROA (TTM)Return on assets | +2.6% | +8.3% | +2.6% | -4.6% |
| ROICReturn on invested capital | +3.9% | +11.3% | +6.7% | -0.6% |
| ROCEReturn on capital employed | +4.0% | +13.0% | +7.5% | -0.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 5 | 2 |
| Debt / EquityFinancial leverage | 0.81x | 0.68x | 0.84x | 0.92x |
| Net DebtTotal debt minus cash | $1.4B | $21.9B | $4.5B | $2.3B |
| Cash & Equiv.Liquid assets | $511M | $5.1B | $566M | $429M |
| Total DebtShort + long-term debt | $1.9B | $27.0B | $5.1B | $2.7B |
| Interest CoverageEBIT ÷ Interest expense | 3.61x | 34.52x | 2.22x | -1.08x |
Total Returns (Dividends Reinvested)
LIN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LIN five years ago would be worth $17,394 today (with dividends reinvested), compared to $6,018 for HUN. Over the past 12 months, HUN leads with a +37.5% total return vs EMN's +2.3%. The 3-year compound annual growth rate (CAGR) favors LIN at 11.8% vs HUN's -12.6% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +16.0% | +15.5% | +15.8% | +45.5% |
| 1-Year ReturnPast 12 months | +4.1% | +11.2% | +2.3% | +37.5% |
| 3-Year ReturnCumulative with dividends | +2.3% | +39.7% | +3.4% | -33.3% |
| 5-Year ReturnCumulative with dividends | -22.7% | +73.9% | -28.4% | -39.8% |
| 10-Year ReturnCumulative with dividends | +27.8% | +375.2% | +35.4% | +57.6% |
| CAGR (3Y)Annualised 3-year return | +0.8% | +11.8% | +1.1% | -12.6% |
Risk & Volatility
LIN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than HUN's 1.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 94.7% from its 52-week high vs AVNT's 81.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.19x | 0.24x | 1.36x | 1.73x |
| 52-Week HighHighest price in past year | $44.85 | $521.28 | $84.18 | $15.89 |
| 52-Week LowLowest price in past year | $27.48 | $387.78 | $56.11 | $7.30 |
| % of 52W HighCurrent price vs 52-week peak | +81.4% | +94.7% | +87.5% | +92.7% |
| RSI (14)Momentum oscillator 0–100 | 55.2 | 51.7 | 56.9 | 65.4 |
| Avg Volume (50D)Average daily shares traded | 620K | 2.3M | 1.5M | 6.2M |
Analyst Outlook
Evenly matched — AVNT and HUN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AVNT as "Buy", LIN as "Buy", EMN as "Buy", HUN as "Hold". Consensus price targets imply 32.6% upside for AVNT (target: $48) vs -18.6% for HUN (target: $12). For income investors, HUN offers the higher dividend yield at 5.74% vs LIN's 1.21%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $48.40 | $539.71 | $77.29 | $12.00 |
| # AnalystsCovering analysts | 20 | 28 | 35 | 33 |
| Dividend YieldAnnual dividend ÷ price | +2.9% | +1.2% | +4.5% | +5.7% |
| Dividend StreakConsecutive years of raises | 14 | 6 | 12 | 0 |
| Dividend / ShareAnnual DPS | $1.08 | $6.00 | $3.30 | $0.85 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | +2.0% | +1.2% | +0.1% |
LIN leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HUN leads in 1 (Valuation Metrics). 1 tied.
AVNT vs LIN vs EMN vs HUN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AVNT or LIN or EMN or HUN a better buy right now?
For growth investors, Linde plc (LIN) is the stronger pick with 3.
0% revenue growth year-over-year, versus -6. 7% for Eastman Chemical Company (EMN). Eastman Chemical Company (EMN) offers the better valuation at 18. 0x trailing P/E (12. 5x forward), making it the more compelling value choice. Analysts rate Avient Corporation (AVNT) a "Buy" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AVNT or LIN or EMN or HUN?
On trailing P/E, Eastman Chemical Company (EMN) is the cheapest at 18.
0x versus Avient Corporation at 41. 0x. On forward P/E, Avient Corporation is actually cheaper at 12. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Linde plc wins at 1. 09x versus Eastman Chemical Company's 3. 89x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — AVNT or LIN or EMN or HUN?
Over the past 5 years, Linde plc (LIN) delivered a total return of +73.
9%, compared to -39. 8% for Huntsman Corporation (HUN). Over 10 years, the gap is even starker: LIN returned +375. 2% versus AVNT's +27. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AVNT or LIN or EMN or HUN?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
24β versus Huntsman Corporation's 1. 73β — meaning HUN is approximately 622% more volatile than LIN relative to the S&P 500. On balance sheet safety, Linde plc (LIN) carries a lower debt/equity ratio of 68% versus 92% for Huntsman Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — AVNT or LIN or EMN or HUN?
By revenue growth (latest reported year), Linde plc (LIN) is pulling ahead at 3.
0% versus -6. 7% for Eastman Chemical Company (EMN). On earnings-per-share growth, the picture is similar: Linde plc grew EPS 7. 1% year-over-year, compared to -51. 6% for Avient Corporation. Over a 3-year CAGR, LIN leads at 0. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AVNT or LIN or EMN or HUN?
Linde plc (LIN) is the more profitable company, earning 20.
3% net margin versus -4. 8% for Huntsman Corporation — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus -0. 7% for HUN. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AVNT or LIN or EMN or HUN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Linde plc (LIN) is the more undervalued stock at a PEG of 1. 09x versus Eastman Chemical Company's 3. 89x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Avient Corporation (AVNT) trades at 12. 0x forward P/E versus 27. 7x for Linde plc — 15. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVNT: 32. 6% to $48. 40.
08Which pays a better dividend — AVNT or LIN or EMN or HUN?
All stocks in this comparison pay dividends.
Huntsman Corporation (HUN) offers the highest yield at 5. 7%, versus 1. 2% for Linde plc (LIN).
09Is AVNT or LIN or EMN or HUN better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
24), 1. 2% yield, +375. 2% 10Y return). Huntsman Corporation (HUN) carries a higher beta of 1. 73 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIN: +375. 2%, HUN: +57. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AVNT and LIN and EMN and HUN?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AVNT is a small-cap quality compounder stock; LIN is a large-cap quality compounder stock; EMN is a small-cap deep-value stock; HUN is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.